Fundraising Fox

OrbiMed β€” 2024 Investments

6 investments dated 2024 Β· listed companies and verified rows first Β· show all

BioAge Labsbioagelabs.comin𝕏NASDAQ: BIOAFeb 2024

BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.

BiotechHealthtechLongevityRichmond, US

Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Executive Officer, Director)inEric Morgen(Director)Dov Goldstein(Executive Officer)

BoardPatrick Enright(Director)in

Co-investorsAndreessen HorowitzElad GilFelicis VenturesIA Seed VenturesLongitude CapitalPear VC+4 more

Averna TherapeuticsApr 2024SEC filingmedium confidence

Creates gene therapies that integrate therapeutic genes into patients' genomes to treat genetic disorders.

HealthtechWatertown, US

Thomas Barnes(Chief Executive Officer/President)Richard Morris(Chief Financial Officer)

BoardRoy Amariglio(Director)Nick Olsen(Director)Michal Silverberg(Director)

Board seatStephen SquintoΒ· per SEC Form D Β· $85M raise Β· filed Mar 2026

Co-investorsDeep InsightNovartis Venture Fund

Belenosbiobelenosbio.comJul 2024

Belenos Biosciences develops long-acting bispecific antibody therapeutics for chronic inflammatory diseases such as COPD, asthma, atopic dermatitis, CRSwNP, and CSU.

BiotechHealthtechNew York, US

Donnie McGrath(CEO & Co-Founder)Megan Dow(COO & Co-Founder)Tania Dimitrova(CFO & Co-Founder)Glenn Rosen(Chief Translational Officer & Co-Founder)StJohn Donnie McGrath(Executive Officer, Director)

BoardBo Chen(Director)

Board seatCarl GordonΒ· per SEC Form D

Candid Therapeuticscandidrx.cominAug 2024

CandidRx develops T-cell engager antibodies to treat autoimmune diseases by redirecting T-cells to eliminate autoreactive B-cells.

BiotechHealthtechSan Diego, US

Ken Song(Chairman, President and CEO)Kenneth Song, M.D.(Executive Officer, Director)Arvind Kush(Executive Officer)Timothy Lu, M.D.(Executive Officer)Bernie Huyghe, Ph.D.(Executive Officer)

BoardJeffrey Tong, Ph.D.(Director)

Co-investorsForesite CapitalSamsara BioCapitalTCG CrossoverThird Rock VenturesvenBio PartnersVida Ventures

Fridomyfrido.comin𝕏Feb 2024

Frido is a consumer brand offering ergonomic and comfort products such as insoles, footwear, cushions, pillows, mattress toppers, and maternity and baby care items, sold direct to consumers and in bulk to businesses.

ConsumerDirect to ConsumerWellness & Fitness

Ganesh Sonawane(Founder)in

Trivenitriveni.bioinOct 2024 Β· $115M

Triveni Bio develops genetics-informed antibody therapeutics aimed at treating complex immunology and inflammation (I&I) diseases.

BiotechDigital HealthHealthtech

Vishal Patelin

Co-investorsAtlas VentureBorealis VenturesBorealis VenturesMagnetic VenturesAscenta CapitalFidelity Investments+3 more

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.